COVID-19: PCR screening of asymptomatic health-care workers at London hospital

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-06-30

Type Journal Article Author Thomas A. Treibel Author Charlotte Manisty Author Maudrian Burton Author Áine McKnight Author Jonathan Lambourne Author João B. Augusto Author Xosé Couto-Parada Author Teresa Cutino-Moguel Author Mahdad Noursadeghi Author James C. Moon URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31100-4/abstract Series The Lancet Correspondence Volume 395 Issue 10237 Pages 1608-1610 Publication The Lancet ISSN 0140-6736, 1474-547X Date 08/05/2020 Extra Publisher: Elsevier PMID: 32401714 Journal Abbr The Lancet DOI 10.1016/S0140-6736(20)31100-4 Accessed 2020-06-30 17:32:43 Library Catalog www.thelancet.com Language English Abstract The exponential growth in coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across the UK has been successfully reversed by social distancing and lockdown.1 RNA testing for prevalent infection is a key part of the exit strategy, but the role of testing for asymptomatic infection remains unclear.2 Understanding the determinants of asymptomatic or pauci-symptomatic infection will provide new opportunities for personalised risk stratification and reveal much-needed correlates of protective immunity, whether induced by vaccination or natural exposure. Short Title COVID-19